1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6713B03611D28199F85257D32004E72B5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/713B03611D28199F85257D32004E72B5!OpenDocument
18
19OpenDocument
2034.207.230.188
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Thought Leader Services

Document Excerpt: Optimizing KOL Relationships: Successful Companies and Lessons Learned

DB Image

ID: MD-426


Features:

13 Info Graphics

11 Data Graphics

50 Metrics

1 Narratives


Pages/Slides: 4


Published: Pre-2016


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click "
Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5322 "Optimizing KOL Relationships: Successful Companies and Lessons Learned."

Industries Profiled:
Biotech; Medical Device; Pharmaceutical; Health Care; Education; Science; Manufacturing; Consumer Products; Diagnostic; Chemical


Companies Profiled:
Biogen Idec; Baxter Healthcare; Medtronic; Teva Pharmaceutical Industries Ltd; Ortho-Clinical Diagnostics; Torrent Pharmaceuticals Ltd.; Reliance Institute of Life Sciences; Lupin; Bayer; ViiV Healthcare; AstraZeneca; Onyx Pharmaceuticals; Johnson & Johnson; LEO Pharma; Abbvie; AUSA; Genentech

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.